SEARCH
Enter your search term below:
SEARCH RESULTS
Your search for '' returned results, displayed below.
Refine your search term or search again:
2007
Flock Mobility Helps Tesla to Provide Environmentally Sustainable Customer Service Options
News | Emma Blunt | Thu, 23/12/2021 | 10:17
SETsquared Surrey member, Flock Mobility, an innovative, sustainable ‘transport as a service’ provider, has provided its shared electric fleet solution to electric vehicle (EV) manufacturer, Tesla. Flock Mobility helps to redefine the way that employees and guests travel to or from the workplace, by offering them multiple sharing options within...
Benetalk Receives European Funding Through the European Institute of Innovation and Technology (EIT) Bridgehead Programme
News | Emma Blunt | Thu, 23/12/2021 | 09:45
SETsquared Surrey member, BeneTalk, an innovative digital speech therapy solution and community, has recently been announced as a recipient of a specialist European Grant. BeneTalk was formed to help people who stutter to communicate more comfortably. EIT Health’s Bridgehead programme was set up to support start-ups such as BeneTalk, who...
Sustainable Design and its importance to reduce impact – Registration Page
Content Page | Karina Moore | Mon, 20/12/2021 | 11:40
Sustainable Design and its importance to reduce impact REGISTRATION SUBMITTED
ICURe Sprint project summaries
Content Page | SETsquared Intern | Tue, 14/12/2021 | 12:11
ICURe Sprint: Energy & Environmental Technologies Project summaries Six exciting and commercially-promising research projects were selected to participate in the inaugural ICURe Sprint cohort.
Anti-ageing technology scoops prestigious clinical award
News | Emma Blunt | Tue, 14/12/2021 | 10:07
SETsquared Exeter and Scale-Up member, SENISCA, has won the ‘Best Start-Up Biotech Company’ award at the OBN Awards 2021. The prestigious OBN Awards, now in their 13th year, shine a light on companies at all stages of development, recognising inspirational leadership, exciting innovation, novel and exciting approaches to unmet clinical need, outstanding company...
